Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

NRIXNRIX
24 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in NURIX THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 4.7M shares of NRIX (NURIX THERAPEUTICS INC), worth $113M as of 2026-Q2. NRIX represents 0.6% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$113M

Current Shares

4.7M

Total Value Change

+$50.6M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.7M
0.0%
$113M0.6%$24.26
0
2026-Q1
Unchanged
4.7M
0.0%
$72.2M0.4%$15.81
0
2025-Q4
Increased
4.7M
+20.0%
$88.4M0.5%$19.02
50
2025-Q3
Unchanged
3.9M
0.0%
$35.9M0.3%$9.28
0
2025-Q2
Unchanged
3.9M
0.0%
$44.2M0.4%$11.64
0
2025-Q1
Unchanged
3.9M
0.0%
$46.1M0.5%$12.15
0
2024-Q4
Unchanged
3.9M
0.0%
$73.1M0.8%$18.64
0
2024-Q3
Unchanged
3.9M
0.0%
$87.2M0.9%$23.05
0
2024-Q2
Unchanged
3.9M
0.0%
$81M1.0%$20.87
0
2024-Q1
Unchanged
3.9M
0.0%
$57.1M0.7%$14.70
0
2023-Q4
Unchanged
3.9M
0.0%
$40.1M0.5%$10.32
0
2023-Q3
Unchanged
3.9M
0.0%
$30.5M0.2%$7.86
0
2023-Q2
Unchanged
3.9M
0.0%
$38.8M0.2%$10.00
0
2023-Q1
Unchanged
3.9M
0.0%
$34.5M0.2%$8.63
0
2022-Q4
Unchanged
3.9M
0.0%
$42.6M0.3%$10.98
0
2022-Q3
Unchanged
3.9M
0.0%
$50.6M0.3%$12.89
0
2022-Q2
Increased
3.9M
+58.2%
$49.2M0.3%$12.51
50
2022-Q1
Unchanged
2.5M
0.0%
$34.4M0.2%$14.17
0
2021-Q4
Unchanged
2.5M
0.0%
$71M0.3%$29.98
0
2021-Q3
Unchanged
2.5M
0.0%
$73.5M0.3%$29.48
0
2021-Q2
Unchanged
2.5M
0.0%
$65.1M0.3%$27.75
0
2021-Q1
Increased
2.5M
+37.2%
$76.3M0.3%$28.32
46
2020-Q4
Unchanged
1.8M
0.0%
$58.8M0.2%$35.30
0
2020-Q3
New
1.8M
-
$62.5M0.2%$33.32
49

Other major holders of NRIX: BlackRock, Inc., FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used